Arno Gutleb, founder and Managing Director of INVITROLIZE talks about his biotech spin-off that supports industries in developing safer products.

Founded in 2022 INVITROLIZE commercializes a unique patented technology developed at the Luxembourg Institute of Science and Technology.

This technology supports industries to identify chemicals and materials very early in product development, which may induce asthma in workers or consumers.

Once chemicals are classified as having such properties, they face restrictions in their use and such news may damage a company's reputation.